Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor

被引:72
|
作者
Creamer, D
Allen, M
Jaggar, R
Stevens, R
Bicknell, R
Barker, J
机构
[1] Kings Coll Hosp London, St Johns Inst Dermatol, St Thomas Hosp, London SE5 9RS, England
[2] Imperial Canc Res Fund, Inst Mol Med, Mol Angiogenesis Grp, Oxford, England
[3] St Thomas Hosp, Dept Rheumatol, London, England
关键词
D O I
10.1001/archderm.138.6.791
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Severe forms of psoriasis can be complicated by systemic microvascular hyper-permeability. Vascular endothelial growth factor (VEGF) possesses potent vascular permeability activity. We suggest that VEGF enters the systemic circulation and acts on microvessels to mediate hyperpermeability. Objectives: To quantify renal microvascular permeability and circulating VEGF concentration in severe psoriasis, and to investigate the relationship between plasma VEGF concentration and skin and joint involvement. Design: Inception cohort studies of patients with generalized pustular psoriasis and plaque psoriasis. Setting: St John's Institute of Dermatology, London, England. Patients: Twenty-two patients (15 men and 7 women) with moderate and severe psoriasis were recruited (age range, 29-77 years; mean age, 47 years); 5 had generalized pustular psoriasis, 2 had erythrodermic psoriasis, and 15 had moderate-severe plaque psoriasis. An age- and sex-matched control group of 17 individuals (10 men and 7 women) was recruited (age range, 29-69 years; mean age, 42 years). Results: There was pathological proteinuria in patients with relapsing generalized pustular psoriasis, (4-fold increase in urinary protein excretion rate in relapse compared with remission). In patients with moderate and severe psoriasis, mean plasma VEGF concentration during relapse was approximately 2.5 times greater than during remission (mean VEGF(relapse)=257 pg/mL; mean VEGF(remission)=103 pg/mL; P<.01). There was a correlation between extent of skin involvement and plasma VEGF level (mean VEGF(severe) (psoriasis) = 365 pg/ml; mean VEGF(moderate psoriasis) = 149 pg/mL; P=.03). There was a correlation between presence of psoriatic arthritis and plasma VEGF level (mean relapse VEGF(arthritis)=277 pg/mL; mean relapse VEGF(nonarthritis),= 103.5 pg/mL; P=.03). Conclusions: Generalized pustular psoriasis is accompanied by pathological proteinuria and elevated plasma VEGF levels. Plasma VEGF concentration is significantly elevated in patients with extensive skin and joint involvement and may act on renal microvasculature to induce hyperpermeability.
引用
收藏
页码:791 / 796
页数:6
相关论文
共 50 条
  • [1] Vascular endothelial growth factor and psoriasis
    Young, HS
    Summers, AM
    Bhushan, M
    Brencheley, PEC
    Griffiths, CEM
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (04) : 852 - 852
  • [2] Vascular permeability factor vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
    Dvorak, HF
    Nagy, JA
    Feng, D
    Brown, LF
    Dvorak, AM
    VASCULAR GROWTH FACTORS AND ANGIOGENESIS, 1999, 237 : 97 - 132
  • [3] VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR, MICROVASCULAR HYPERPERMEABILITY, AND ANGIOGENESIS
    DVORAK, HF
    BROWN, LF
    DETMAR, M
    DVORAK, AM
    AMERICAN JOURNAL OF PATHOLOGY, 1995, 146 (05): : 1029 - 1039
  • [4] Circulating vascular permeability factor vascular endothelial growth factor in erythroderma
    Creamer, D
    Allen, MH
    Groves, RW
    Barker, JNWN
    LANCET, 1996, 348 (9034): : 1101 - 1101
  • [5] Vascular endothelial growth factor in pathogenesis of psoriasis
    Zaniewski, Przemyslaw
    Flisiak, Iwona
    Chodynicka, Bozena
    PRZEGLAD DERMATOLOGICZNY, 2010, 97 (06): : 406 - 412
  • [6] Heparan Sulfate is an Essential Regulator of Vascular Endothelial Growth Factor Induced Vascular Hyperpermeability
    Xu, Ding
    Fuster, Mark
    Lawrence, Roger
    Esko, Jeffrey
    GLYCOBIOLOGY, 2009, 19 (11) : 1317 - 1317
  • [7] Circulating levels of vascular endothelial growth factor (VEGF)-C in systemic sclerosis
    Chitale, S
    Herrick, A
    Kumar, S
    Edge, K
    Al-Mowlland, F
    RHEUMATOLOGY, 2005, 44 : I128 - I128
  • [8] Adrenomedullin Suppresses Vascular Endothelial Growth Factor-Induced Vascular Hyperpermeability and Inflammation in Retinopathy
    Imai, Akira
    Toriyama, Yuichi
    Iesato, Yasuhiro
    Hirabayashi, Kazutaka
    Sakurai, Takayuki
    Kamiyoshi, Akiko
    Ichikawa-Shindo, Yuka
    Kawate, Hisaka
    Tanaka, Megumu
    Liu, Tian
    Xian, Xian
    Zhai, Liuyu
    Dai, Kun
    Tanimura, Keiya
    Liu, Teng
    Cui, Nanqi
    Yamauchi, Akihiro
    Murata, Toshinori
    Shindo, Takayuki
    AMERICAN JOURNAL OF PATHOLOGY, 2017, 187 (05): : 999 - 1015
  • [9] Alterations in vascular endothelial growth factor biology in psoriasis
    Young, HS
    Summers, AM
    Brenchley, PEC
    Griffiths, CEM
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 11 - 11
  • [10] Vascular endothelial growth factor and placenta growth factor initiate endothelial monolayer hyperpermeability by distinct signaling mechanisms
    Schaeffer, RC
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 242A - 243A